Nusano News
Nusano and Ariceum Therapeutics Announce Multi-Isotope Supply Agreement
Agreement includes Actinium-225 (Ac-225) and Lutetium-177 (Lu-177) to support Ariceum’s therapeutic programsWEST VALLEY CITY, Utah and BERLIN, Germany – Oct. 14, 2025 –...
Nusano Opens Radiochemistry Laboratory to Advance Isotope Commercialization and Customer Collaboration
Photo above: On Friday, March 8, 2024, representatives from Nusano and The Wasatch Group cut the ribbon on the Radiance Lab, a 5,000 square foot radiochemistry space that will develop radioisotope separation and purification processes for Nusano. (L-to-R) Howard...
Nusano to Participate in the B. Riley Securities Radiopharma Investor Conference
VALENCIA, Calif. – February 26, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced it will participate in a presentation and panel at the B. Riley Securities Radiopharma Investor Conference in New York City on...
Nusano Names Rohan Jain as Commercial General Manager
VALENCIA, Calif. – Jan. 22, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced Rohan Jain as its Commercial General Manager. Jain and his team will work with Nusano’s customers and prospects to assess their needs and...
Nusano to Host December 19 Virtual KOL Event on Emerging Trends in Radiotherapeutics
EVENT REPLAY NOW AVAILABLE Recorded December 19, 2023Press release updated December 14, 2023 to include addition of Dr. OrozcoVALENCIA, Calif. – Dec. 12, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will...
Nusano to Participate in October Investor Conferences
Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced that senior management will participate in the following investor conferences in October.
Nusano Appoints Industry Expert Alexandre Gibim as Chief Operations Officer
Nusano, Inc. has appointed pharmaceutical executive Alexandre Gibim as the company’s Chief Operations Officer (COO). Gibim will be responsible for enabling and scaling Nusano’s business functions to create a reliable domestic and global supply of medical radioisotopes, the active pharmaceutical ingredients (APIs) at the core of next-generation cancer therapeutics.
Video Replay: Unlocking the Next $20-30B Market Opportunity in Oncology: Radioisotope Production & Applications
With many now expecting radiopharmaceuticals to grow into a $20-30 billion market, investors are increasingly looking at the obstacles and opportunities for suppliers and drugmakers in this space. To advance these discussions, on Friday, May 12, 2023, Nusano and...
Nusano to Participate in Isotope and Radiopharmaceutical Conferences
Nusano, Inc., a company working to stabilize and enable the production of cancer-fighting radioisotopes, is participating in two conferences in July 2023.
Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
Nusano and PharmaLogic will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.
Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian
Nusano is creating an in-house stable isotope program to enhance the company’s medical radioisotope production capabilities and decrease dependence on foreign supply chains.
BLOG Posts
Nusano Named to Insights Care 5 Most Trusted Radiopharmaceutical Companies to Watch
September 2024 – Insights Care recently interviewed Nusano CEO Chris Lowe for its "5 Most Trusted Radiopharmaceutical...
Nusano Featured in Biosphere Magazine
Nusano is featured in the 2024 edition of Biosphere magazine entitled "Profiles in Innovation." Published by BioUtah,...
MedicalXpress: Researchers develop new method of precisely targeting cancer lesions while protecting healthy tissues
From MedicalXpress: A team of researchers has developed a new method that suppresses the distribution of drugs to...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates